COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005
Bronchodilator tolerance: the impact of increasing bronchoconstriction Source: Eur Respir J 2003; 21: 810-815 Year: 2003
R411 treatment reduces asthma exacerbations and attenuates FEV1 fall following steroid withdrawal in moderate asthma Source: Eur Respir J 2005; 26: Suppl. 49, 252s Year: 2005
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018
Mechanisms of improved exercise tolerance in COPD in response to tiotropium Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol Source: Eur Respir J 2001; 17: 368-373 Year: 2001
Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
Predictors of asthma exacerbation after treatment cessation Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Increased respiratory symptoms in COPD patients on withdrawal of therapy: evidence of long-term efficacy gains with formoterol turbuhaler Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015
Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma Source: Eur Respir J 2001; 17: 374-379 Year: 2001
Three month treatment with formoterol in mild asthma: efficacy and side effects Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006
Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children Source: Eur Respir J 2006; 28: 291-295 Year: 2006
Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013
Persistent blood eosinophilia and COPD exacerbation risk after ICS withdrawal from triple therapy in the SUNSET study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020